Association for Accessible Medicines
FDANonrulemakingFDA-2024-D-2581

Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers; Draft Guidance for Industry; Availability

RIN
Last modified
Sep 24, 2024
Comment window
closed 673d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Sep 24, 2024 and Sep 24, 2024. 0 other organizations filed here. The comment window closed 673d ago.

What Association for Accessible Medicines filed (1)

Sep 24, 2024· Comment from Association for Accessible Medicines and Biosimilars Council· FDA-2024-D-2581-0008

Comment submitted by Association for Accessible Medicines and Biosimilars Council

Abstract

Open

View on regulations.gov →